Source: Annual Congress 2005 - Epidemiology of COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Jimenez-Garcia, M. C. Ariez-Fernandez, P. Carrasco, M. M. Garcia-Carballo, A. Martin, E. Gobartt, A. Gil de Miguel (Alcorcon, Madrid, Barcelona, Spain). Compliance with the pneumococcal and influenza vaccination recommendations in patients with COPD in Catalonia (Spain). Eur Respir J 2005; 26: Suppl. 49, 3798

Member's Comments

No comment yet.

Related content which might interest you: Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Hospitalizations from pandemic influenza (pH1N1) infections among patients with COPD in Spain Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Hospitalizations from pandemic influenza (pH1N1) infections among patients with asthma in Spain Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013) Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 How the COVID19 pandemic changed the attitude versus seasonal flu vaccination among COPD patients in Serbia Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved. Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13) Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Impact of influenza vaccination in patients with CAP Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Pneumococcal and influenza vaccine uptake in patients discharged from an acute medical hospital Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 The burden of hospitalized all-cause and pneumococcal pneumonia in Spain (2010) Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Can the influenza vaccine response be predicted in COPD patients by clinical parameters? Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Influenza vaccination in COPD Source: International Congress 2019 – Vaccines against respiratory infections Year: 2019 Seasonal influenza vaccination in Canadian adolescents with and without asthma. Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 Influenza A/H1N1 vaccination in lung a transplant program: Coverage, safety and clinical effectiveness during the pandemic 2009/2010 Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Provision of influenza immunisation for UK HIV positive adults Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016